Plasma miR-122 levels in chronic hepatitis C patients achieving sustained virological response following DAA treatment with and without previous anti-miR-122 (RG-101) dosing von van der Ree, M.H, Stelma, F, Willemse, S.B, van der Valk, M, de Vree, J.M.L, Kootstra, N.A, Reesink, H.W

Volltext

Sequence Analysis for Resistance Monitoring following a Single Dose of RG-101, an Anti-MIR Targeting Microrna-122, in Chronic Hepatitis C Patients von van der Ree, M.H, Stelma, F, de Vree, J.M.L, Willemse, S.B, van der Valk, M, van Nuenen, Ad.C, Patick, A, Grint, P, Neben, S, Pavlicek, A, van der Veer, E, Kootstra, N.A, Reesink, H.W

Volltext

SAT-235 - Plasma miR-122 levels in chronic hepatitis C patients achieving sustained virological response following DAA treatment with and without previous anti-miR-122 (RG-101) dos... von van der Ree, M.H., Stelma, F., Willemse, S.B., van der Valk, M., de Vree, J.M.L., Kootstra, N.A., Reesink, H.W.

Volltext

THU-232 - Sequence Analysis for Resistance Monitoring following a Single Dose of RG-101, an Anti-MIR Targeting Microrna-122, in Chronic Hepatitis C Patients von van der Ree, M.H., Stelma, F., de Vree, J.M.L., Willemse, S.B., van der Valk, M., van Nuenen, Ad.C., Patick, A., Grint, P., Neben, S., Pavlicek, A., van der Veer, E., Kootstra, N.A., Reesink, H.W.

Volltext

99. TPN in critically ill patients: the influence on bile secretion von de Vree, J.M.L., Mathus-Vliegen, E.M.H., Ostrow, J.D., Sauerwein, H.P., Stoutenbeek, C.P., Tytgat, G.N.J., Oude Elferink, R.P.J., Groen, A.K., Romijn, J.A.

Volltext